Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus (Q43104660)
Jump to navigation
Jump to search
scientific article published in April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus |
scientific article published in April 2010 |
Statements
1 reference
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus (English)
1 reference
1 reference
1 reference
K Aaboe
1 reference
F K Knop
1 reference
T Vilsbøll
1 reference
C F Deacon
1 reference
T Krarup
1 reference
1 April 2010
1 reference
1 reference
Identifiers
1 reference